237 related articles for article (PubMed ID: 2391071)
21. Scintigraphic documentation of an improvement in hepatobiliary excretory function after treatment with ursodeoxycholic acid in patients with cystic fibrosis and associated liver disease.
Colombo C; Castellani MR; Balistreri WF; Seregni E; Assaisso ML; Giunta A
Hepatology; 1992 Apr; 15(4):677-84. PubMed ID: 1551646
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of an oral ursodeoxycholic acid load in the assessment of bile acid malabsorption in cystic fibrosis.
Colombo C; Roda A; Roda E; Piceni Sereni L; Maspero D; Giunta AM; Barbara L
Dig Dis Sci; 1983 Apr; 28(4):306-11. PubMed ID: 6831994
[TBL] [Abstract][Full Text] [Related]
23. Hepatic bile acid metabolism during early development revealed from the analysis of human fetal gallbladder bile.
Setchell KD; Dumaswala R; Colombo C; Ronchi M
J Biol Chem; 1988 Nov; 263(32):16637-44. PubMed ID: 3182806
[TBL] [Abstract][Full Text] [Related]
24. Enrichment of bile with tauroursodeoxycholic acid and biliary cholesterol saturation in hamsters.
Handelsman B; Bonorris G; Marks JW; Schoenfield LJ
Am J Physiol; 1982 Nov; 243(5):G424-7. PubMed ID: 7137357
[TBL] [Abstract][Full Text] [Related]
25. Ursodeoxycholic acid in the Ursidae: biliary bile acids of bears, pandas, and related carnivores.
Hagey LR; Crombie DL; Espinosa E; Carey MC; Igimi H; Hofmann AF
J Lipid Res; 1993 Nov; 34(11):1911-7. PubMed ID: 8263415
[TBL] [Abstract][Full Text] [Related]
26. N-acetylglucosaminides. A new type of bile acid conjugate in man.
Marschall HU; Egestad B; Matern H; Matern S; Sjövall J
J Biol Chem; 1989 Aug; 264(22):12989-93. PubMed ID: 2753897
[TBL] [Abstract][Full Text] [Related]
27. Ursocholic acid, a hydrophilic bile acid, fails to improve liver function parameters in primary biliary cirrhosis: comparison with ursodeoxycholic acid.
Batta AK; Salen G; Abroon J
Am J Gastroenterol; 1997 Jun; 92(6):1035-7. PubMed ID: 9177526
[TBL] [Abstract][Full Text] [Related]
28. Cystic fibrosis. Is treatment with ursodeoxycholic acid of value?
Strandvik B; Lindblad A
Scand J Gastroenterol Suppl; 1994; 204():65-7. PubMed ID: 7824881
[TBL] [Abstract][Full Text] [Related]
29. Increase of sulfated ursodeoxycholic acid in the serum and urine of patients with chronic liver disease after ursodeoxycholic acid therapy.
Nakamura K; Yoneda M; Kimura A; Tamori K; Yokohama S; Sato Y; Kato T; Hasegawa T; Saito H; Aoshima M; Fujita M; Makino I
J Gastroenterol Hepatol; 1996 Apr; 11(4):385-90. PubMed ID: 8713707
[TBL] [Abstract][Full Text] [Related]
30. Effect of ursodeoxycholic acid administration on biliary lipid secretion in primary biliary cirrhosis.
Roda E; Mazzella G; Bazzoli F; Villanova N; Minutello A; Simoni P; Ronchi M; Poggi C; Festi D; Aldini R
Dig Dis Sci; 1989 Dec; 34(12 Suppl):52S-58S. PubMed ID: 2598768
[TBL] [Abstract][Full Text] [Related]
31. delta 22-Ursodeoxycholic acid, a unique metabolite of administered ursodeoxycholic acid in rats, indicating partial beta-oxidation as a major pathway for bile acid metabolism.
Setchell KD; Yamashita H; Rodrigues CM; O'Connell NC; Kren BT; Steer CJ
Biochemistry; 1995 Apr; 34(13):4169-78. PubMed ID: 7703228
[TBL] [Abstract][Full Text] [Related]
32. Long-term prospective study of the effect of ursodeoxycholic acid on cystic fibrosis-related liver disease.
Nousia-Arvanitakis S; Fotoulaki M; Economou H; Xefteri M; Galli-Tsinopoulou A
J Clin Gastroenterol; 2001 Apr; 32(4):324-8. PubMed ID: 11276276
[TBL] [Abstract][Full Text] [Related]
33. Pharmacology of ursodeoxycholic acid, an enterohepatic drug.
Hofmann AF
Scand J Gastroenterol Suppl; 1994; 204():1-15. PubMed ID: 7824870
[TBL] [Abstract][Full Text] [Related]
34. The effect of diet on bile acid kinetics and biliary lipid secretion in gallstone patients treated with ursodeoxycholic acid.
Frenkiel PG; Lee DW; Cohen H; Gilmore CJ; Resser K; Bonorris GG; Marks JW; Schoenfield LJ
Am J Clin Nutr; 1986 Feb; 43(2):239-50. PubMed ID: 3004189
[TBL] [Abstract][Full Text] [Related]
35. Ursodeoxycholic acid, 7-ketolithocholic acid, and chenodeoxycholic acid are primary bile acids of the nutria (Myocastor coypus).
Tint GS; Bullock J; Batta AK; Shefer S; Salen G
Gastroenterology; 1986 Mar; 90(3):702-9. PubMed ID: 3943698
[TBL] [Abstract][Full Text] [Related]
36. Effect of ursodeoxycholic acid on bile acid metabolism in primary biliary cirrhosis.
Batta AK; Salen G; Arora R; Shefer S; Tint GS; Abroon J; Eskreis D; Katz S
Hepatology; 1989 Oct; 10(4):414-9. PubMed ID: 2777202
[TBL] [Abstract][Full Text] [Related]
37. Simultaneous determination of biliary cile acids in rat: electron impact and ammonia chemical ionization mass spectrometric analyses of bile acids.
Kuriyama K; Ban Y; Nakashima T; Murata T
Steroids; 1979; 34(6 Spec no):717-28. PubMed ID: 538777
[TBL] [Abstract][Full Text] [Related]
38. Effects of taurine and ursodeoxycholic acid on liver function tests in patients with cystic fibrosis.
Colombo C; Battezzati PM; Crosignani A; Assaisso M; Ronchi M; Giunta A
Acta Univ Carol Med (Praha); 1990; 36(1-4):148-51. PubMed ID: 2130679
[TBL] [Abstract][Full Text] [Related]
39. Effect of litholytic bile acids on cholesterol absorption in gallstone patients.
LaRusso NF; Thistle JL
Gastroenterology; 1983 Feb; 84(2):265-71. PubMed ID: 6848406
[TBL] [Abstract][Full Text] [Related]
40. Differing effects of ursodeoxycholic or chenodeoxycholic acid on biliary cholesterol saturation and bile acid metabolism in man. A dose-response study.
Thistle JL; Larusso NF; Hofmann AF; Turcotte J; Carlson GL; Ott BJ
Dig Dis Sci; 1982 Feb; 27(2):161-8. PubMed ID: 7075411
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
